Project Grant R01DA060857
Award Date
7/1/25
Completion Date
3/31/30
Dollars Obligated
$771K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $594,122 Project Grant to Boulder Care, Inc. to develop and test telehealth workflows for providing buprenorphine treatment for opioid use disorder (OUD) in vulnerable settings. The project aims to address the continued lack of access to OUD treatment, particularly in jails/prisons, emergency departments, residential treatment facilities, rural tribal areas, and during the...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
This Project Grant award of $1,749,422 from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) supports an evaluation of telehealth's role in buprenorphine treatment initiation and retention, overdose mortality, and access equity for the purpose of informing policy development. The primary awardee, The General Hospital Corporation (doing business as Massachusetts General Hospital), will subcontract with...
The National Institute on Drug Abuse (NIDA) awarded a $1,994,766 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Cambridge Public Health Commission, doing business as Cambridge Health Alliance (CHA), to assess the causal impact and equity effects of the New York State Medicaid Value-Based Payment (VBP) policy on opioid use disorder (OUD)-related outcomes. The key products and services to be delivered under this 2-year grant, which begins on August 1, 2024,...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a 5-year study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The research aims to: 1) characterize real-world OUD treatment trajectories in the year following hospital encounters among treatment-naive...
This federal Project Grant award of $421,200.00, provided by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs), aims to develop new chemical biology tools to study the interactions between cannabinoid and opioid receptors in the brain's reward system. The goal is to better understand the role of cannabinoid receptors in opioid use disorder (OUD) and identify potential therapeutic targets. The award, with a project period from August 2024 to May 2029,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...
This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...
This $512,256 Project Grant from the National Institutes of Health's National Institute on Drug Abuse will support Health Outcomes Inc. doing business as Telesage to develop a Primary Care-SUD Intake System (P-SUD-IS). The P-SUD-IS aims to address underdiagnosis of substance use disorders (SUDs) by streamlining the SUD assessment process for primary care clinicians. Telesage will create a HIPAA-compliant, automated, cloud-based system to facilitate completion of biopsychosocial assessments for...
This $1,192,612 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to integrate HIV prevention services into clinical care settings for people with opioid use disorder (OUD). The key objectives are to: 1) conduct a systematic assessment of healthcare utilization, HIV prevention services, and medication for OUD (MOUD) using claims and emergency department data; 2) use an evidence-based quality improvement...